PL3480200T3 - Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca - Google Patents

Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Info

Publication number
PL3480200T3
PL3480200T3 PL17820539.9T PL17820539T PL3480200T3 PL 3480200 T3 PL3480200 T3 PL 3480200T3 PL 17820539 T PL17820539 T PL 17820539T PL 3480200 T3 PL3480200 T3 PL 3480200T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
same
optically active
phenol derivative
pyranochromenyl phenol
Prior art date
Application number
PL17820539.9T
Other languages
English (en)
Inventor
Sang Ku Yoo
Jin Wook Chung
In Geun Jo
Ji Young Kim
Jeong Ho Im
Ku Suk Kang
Jin Young Kim
Original Assignee
Glaceum, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaceum, Inc. filed Critical Glaceum, Inc.
Publication of PL3480200T3 publication Critical patent/PL3480200T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL17820539.9T 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca PL3480200T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160081674 2016-06-29
PCT/KR2017/006863 WO2018004263A1 (ko) 2016-06-29 2017-06-29 광학 활성 피라노크로메닐페놀 유도체 및 그를 포함하는 약학적 조성물

Publications (1)

Publication Number Publication Date
PL3480200T3 true PL3480200T3 (pl) 2023-01-30

Family

ID=60787377

Family Applications (2)

Application Number Title Priority Date Filing Date
PL22153273.2T PL4023651T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca
PL17820539.9T PL3480200T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL22153273.2T PL4023651T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Country Status (17)

Country Link
US (2) US20190152984A1 (pl)
EP (2) EP3480200B1 (pl)
JP (2) JP2019520381A (pl)
KR (1) KR102388965B1 (pl)
CN (1) CN109476676B (pl)
AU (1) AU2017287746B2 (pl)
BR (1) BR112018077392A2 (pl)
CA (1) CA3028954C (pl)
DK (1) DK4023651T3 (pl)
ES (2) ES2964146T3 (pl)
IL (1) IL263826B2 (pl)
MX (1) MX393450B (pl)
PL (2) PL4023651T3 (pl)
SG (1) SG11201811796SA (pl)
TW (1) TWI731998B (pl)
WO (1) WO2018004263A1 (pl)
ZA (1) ZA201900121B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3524609B1 (en) * 2016-10-04 2021-05-26 Glaceum, Inc. Process for the preparation of 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivatives, optical isomers thereof, and intermediates of the process
KR20200105198A (ko) * 2019-02-28 2020-09-07 주식회사 글라세움 신경계 질환의 예방 또는 치료용 약학적 조성물
EP4353226A4 (en) 2021-06-08 2024-10-16 Glaceum, Inc. PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF DEGENERATIVE EYE DISEASES
KR20240078928A (ko) * 2022-11-28 2024-06-04 가톨릭대학교 산학협력단 침샘 오가노이드 안정화 및 침샘조직 재생 유도 조성물
WO2024151017A1 (ko) 2023-01-12 2024-07-18 주식회사 글라세움 퇴행성 골관절염의 예방 또는 치료용 약학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1599602A (zh) * 2001-10-11 2005-03-23 钟渊化学工业株式会社 过氧化物酶体增殖剂应答性受体配体剂及其制备方法
TW200513194A (en) * 2003-07-31 2005-04-16 Kaneka Corp Fat and oil processed composition for prevention and/or amelioration of life-style related disease
WO2007058480A1 (en) * 2005-11-16 2007-05-24 Md Bioalpha Co., Ltd. Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin
KR102344479B1 (ko) * 2013-12-24 2021-12-29 주식회사 글라세움 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물
KR101742274B1 (ko) 2014-12-31 2017-06-01 주식회사 과학기술분석센타 소규모 상수시설 통합 관리 시스템의 수질 측정 장치
EP3524609B1 (en) * 2016-10-04 2021-05-26 Glaceum, Inc. Process for the preparation of 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivatives, optical isomers thereof, and intermediates of the process

Also Published As

Publication number Publication date
IL263826B2 (en) 2023-05-01
JP2019520381A (ja) 2019-07-18
EP3480200A1 (en) 2019-05-08
EP3480200A4 (en) 2020-02-26
US20190152984A1 (en) 2019-05-23
IL263826A (en) 2019-01-31
US11332475B2 (en) 2022-05-17
CN109476676B (zh) 2021-09-17
AU2017287746A1 (en) 2019-01-17
EP4023651A1 (en) 2022-07-06
NZ749461A (en) 2020-08-28
MX393450B (es) 2025-03-24
KR20180002539A (ko) 2018-01-08
ZA201900121B (en) 2023-04-26
TW201808961A (zh) 2018-03-16
PL4023651T3 (pl) 2024-02-19
SG11201811796SA (en) 2019-02-27
CA3028954A1 (en) 2018-01-04
CA3028954C (en) 2020-10-27
DK4023651T3 (da) 2023-11-20
ES2929931T3 (es) 2022-12-05
BR112018077392A2 (pt) 2019-04-09
AU2017287746B2 (en) 2020-04-09
JP7036871B2 (ja) 2022-03-15
WO2018004263A1 (ko) 2018-01-04
EP4023651B1 (en) 2023-09-13
TWI731998B (zh) 2021-07-01
CN109476676A (zh) 2019-03-15
IL263826B1 (en) 2023-01-01
JP2020186259A (ja) 2020-11-19
US20210094967A1 (en) 2021-04-01
KR102388965B1 (ko) 2022-04-22
EP3480200B1 (en) 2022-10-19
ES2964146T3 (es) 2024-04-04
MX2018016361A (es) 2019-09-16

Similar Documents

Publication Publication Date Title
ZA201802125B (en) Pharmaceutical composition and application thereof
ZA201802003B (en) Dual function proteins and pharmaceutical composition comprising same
IL269061A (en) A pharmaceutical preparation containing Selexifag
EP3094343A4 (en) Rapid action insulin formulations and pharmaceutical delivery systems
EP3233111A4 (en) Pharmaceutical composition comprising plasminogen and uses thereof
EP3307265A4 (en) Pharmaceutical combination and uses thereof
DK3554534T3 (da) Farmaceutisk sammensætning omfattende insulin
ZA201900121B (en) Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
EP3297640A4 (en) Pharmaceutical co-crystal composition and use thereof
PT3202759T (pt) Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo
EP3285758A4 (en) Co-crystal composition and its pharmaceutical use
IL263040A (en) Pharmaceutical composition comprising eteplirsen
IL260321B (en) A multi-antigenic structure and a pharmaceutical preparation containing it
SG10202106375UA (en) Pharmaceutical compositions and use thereof
IL257621B (en) A catechol derivative and a pharmaceutical preparation that includes it
EP3497080A4 (en) PHARMACEUTICAL FORMULATIONS AND THEIR USE
ZA202000959B (en) Adamantylmethylamine derivative and use thereof as pharmaceutical
GB201519644D0 (en) Therapy and pharmaceutical composition
PL3424500T3 (pl) Kompozycja farmaceutyczna zawierająca famitynib
SG11201700122TA (en) Pharmaceutical compound comprising 13 glycerides, formulation and application thereof
IL264083A (en) A pharmaceutical preparation containing benzydamine
HK40006816A (en) Pharmaceutical composition comprising eteplirsen
AU2015902260A0 (en) Pharmaceutical Combination and Uses Thereof
HK1236840B (en) Pharmaceutical composition comprising plasminogen and uses thereof